On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach
PD-1/PD-L1 immune checkpoint blockade for cancer therapy showed promising results in clinical studies. Further endeavors are required to enhance patient stratification, as, at present, only a small portion of patients with PD-L1-positive tumors (as determined by PD-L1 targeted immunohistochemistry;...
Saved in:
Main Authors: | Karsten Bamminger (Author), Verena Pichler (Author), Chrysoula Vraka (Author), Tina Nehring (Author), Katharina Pallitsch (Author), Barbara Lieder (Author), Marcus Hacker (Author), Wolfgang Wadsak (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide
by: Verena Pichler, et al.
Published: (2019) -
Development and Preclinical Evaluation of [<sup>68</sup>Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression
by: Yong Huang, et al.
Published: (2023) -
Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
by: Marius Ozenil, et al.
Published: (2021) -
Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1
by: Marius Ozenil, et al.
Published: (2020) -
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor
by: Antonia Högnäsbacka, et al.
Published: (2022)